VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 492 filers reported holding VANECK VECTORS ETF TR in Q3 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,088 | +19.8% | 2,010 | +34.1% | 0.02% | +27.8% |
Q2 2023 | $45,135 | -82.8% | 1,499 | -79.6% | 0.02% | -84.5% |
Q1 2023 | $262,250 | +16.4% | 7,348 | -3.5% | 0.12% | +24.7% |
Q4 2022 | $225,252 | -21.8% | 7,615 | -20.1% | 0.09% | -30.1% |
Q1 2022 | $288,000 | -34.8% | 9,529 | -29.9% | 0.13% | -37.3% |
Q1 2021 | $442,000 | -54.9% | 13,591 | -50.1% | 0.21% | -57.1% |
Q4 2020 | $981,000 | +152.8% | 27,230 | +175.0% | 0.49% | +195.8% |
Q3 2020 | $388,000 | -3.7% | 9,901 | +2.7% | 0.17% | +2.5% |
Q2 2020 | $403,000 | +65.8% | 9,637 | -8.6% | 0.16% | +43.0% |
Q1 2020 | $243,000 | -30.6% | 10,543 | -11.8% | 0.11% | -21.4% |
Q4 2019 | $350,000 | +20.3% | 11,949 | +14.4% | 0.14% | +81.2% |
Q3 2019 | $291,000 | +9.0% | 10,449 | 0.0% | 0.08% | +3.9% |
Q2 2019 | $267,000 | -7.9% | 10,449 | -19.2% | 0.08% | -4.9% |
Q1 2019 | $290,000 | -30.0% | 12,938 | -34.1% | 0.08% | -39.6% |
Q4 2018 | $414,000 | – | 19,646 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |